Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Colonno

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of Virology|February 11, 1999
pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusionC Cianci, K L Yu, D D Dischino, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymeraseD J Tenney, G Yamanaka, S M Voss, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
Journal of Virology|June 1, 1994
The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growthM Gao, L Matusick-Kumar, W Hurlburt, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitorsR E Rose, Y F Gong, J A Greytok, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replicationC A Deminie, C M Bechtold, D Stock, et al.
The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitorP F Lin, H Samanta, C M Bechtold, et al.
Antiviral Research|October 1, 1993
Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsM Alam, C M Bechtold, A K Patick, et al.
Journal of Virology|April 1, 1995
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitorA K Patick, R Rose, J Greytok, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Virology|February 11, 1999
pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusionC Cianci, K L Yu, D D Dischino, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymeraseD J Tenney, G Yamanaka, S M Voss, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
Journal of Virology|June 1, 1994
The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growthM Gao, L Matusick-Kumar, W Hurlburt, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitorsR E Rose, Y F Gong, J A Greytok, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replicationC A Deminie, C M Bechtold, D Stock, et al.
The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitorP F Lin, H Samanta, C M Bechtold, et al.
Antiviral Research|October 1, 1993
Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsM Alam, C M Bechtold, A K Patick, et al.
Journal of Virology|April 1, 1995
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitorA K Patick, R Rose, J Greytok, et al.
Pageof 8